We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$41.2B
AUM Growth
+$785M
Cap. Flow
-$197M
Cap. Flow %
-0.48%
Top 10 Hldgs %
16.49%
Holding
2,297
New
154
Increased
708
Reduced
1,158
Closed
139

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$171M
2
RF icon
Regions Financial
RF
+$151M
3
BABA icon
Alibaba
BABA
+$109M
4
KO icon
Coca-Cola
KO
+$75.9M
5
AMCR icon
Amcor
AMCR
+$67.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 14.7%
3 Financials 10.86%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
326
Molina Healthcare
MOH
$10.4B
$22.1M 0.05%
154,589
-41,554
-21% -$5.69M
ORLY icon
327
O'Reilly Automotive
ORLY
$75.1B
$21.9M 0.05%
889,500
-43,545
-5% -$1.1M
CAT icon
328
Caterpillar
CAT
$361B
$21.9M 0.05%
160,620
-84,257
-34% -$11.1M
PFGC icon
329
Performance Food Group
PFGC
$18.3B
$21.8M 0.05%
544,040
-11,653
-2% -$467K
PE
330
DELISTED
PARSLEY ENERGY INC
PE
$21.5M 0.05%
1,131,427
+167,657
+17% +$3.21M
PXD
331
DELISTED
Pioneer Natural Resource Co.
PXD
$21.5M 0.05%
139,602
-29,239
-17% -$4.48M
BWA icon
332
BorgWarner
BWA
$12.8B
$21.4M 0.05%
580,346
-1,747
-0.3% -$61.9K
CALA
333
DELISTED
Calithera Biosciences, Inc
CALA
$21.4M 0.05%
274,253
+85,865
+46% +$9.75M
PSN icon
334
Parsons
PSN
$4.31B
$21.3M 0.05%
+579,155
New +$19M
HWC icon
335
Hancock Whitney
HWC
$6.19B
$21.2M 0.05%
529,133
-34,480
-6% -$1.42M
CPAY icon
336
Corpay
CPAY
$25.7B
$21.2M 0.05%
75,427
+74,371
+7,043% +$19.5M
NXPI icon
337
NXP Semiconductors
NXPI
$60.8B
$21M 0.05%
215,610
+112,289
+109% +$10.9M
DOMO icon
338
Domo
DOMO
$171M
$21M 0.05%
767,000
+266,761
+53% +$9.27M
BR icon
339
Broadridge
BR
$18.4B
$20.9M 0.05%
163,499
-51,003
-24% -$6.14M
SRLN icon
340
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$20.8M 0.05%
450,000
+100,000
+29% +$4.64M
FITB
341
Fifth Third Bancorp
FITB
$51.3B
$20.7M 0.05%
742,767
-68,881
-8% -$1.89M
ATRA icon
342
Atara Biotherapeutics
ATRA
$72.6M
$20.7M 0.05%
41,140
+5,008
+14% +$3.53M
GOSS icon
343
Gossamer Bio
GOSS
$101M
$20.7M 0.05%
931,429
+193,429
+26% +$3.7M
SPSC icon
344
SPS Commerce
SPSC
$2.55B
$20.6M 0.05%
402,150
-58,182
-13% -$3.03M
RTN
345
DELISTED
Raytheon Company
RTN
$20.5M 0.05%
118,132
-152,165
-56% -$27.4M
A icon
346
Agilent Technologies
A
$39.6B
$20.5M 0.05%
274,015
-141,265
-34% -$10.5M
GIL icon
347
Gildan
GIL
$9.49B
$20.4M 0.05%
526,509
-12,435
-2% -$464K
ZD icon
348
Ziff Davis
ZD
$2B
$20.3M 0.05%
262,784
+61,489
+31% +$4.65M
BPOP icon
349
Popular Inc
BPOP
$11B
$20.3M 0.05%
374,471
-14,686
-4% -$802K
INSP icon
350
Inspire Medical Systems
INSP
$1.47B
$20.2M 0.05%
333,628
-99
-0% -$5.34K

Similar funds

Federated Hermes's Q2 2019 Portfolio in Review

As of Q2 2019, Federated Hermes held 2,297 positions worth $41.2B, up 1.9% from $40.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2019 filing shows 154 new, 708 increased, 1,158 reduced and 139 closed positions. Its largest new stake was Amcor: 1,210,171 shares worth $69.5M. The largest sale was American Electric Power, an estimated $183M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q2 2019 buy was Amcor: 1,210,171 shares worth $69.5M.
  • Federated Hermes added most to Pfizer in Q2 2019, an estimated $171M increase.
  • Federated Hermes's biggest Q2 2019 reduction was American Electric Power, cutting an estimated $183M.
  • Federated Hermes fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $41.2B portfolio in Q2 2019.
  • Federated Hermes opened 154 new positions and closed 139 in Q2 2019.
  • Federated Hermes's portfolio value rose 1.9% quarter-over-quarter to $41.2B.

Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.